NICHOLAS FISHER: Open Payments
NPI 1003473695 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$999 in 65 payments from 15 companies in 2025. Trend: 2023 $1,271 · 2024 $1,429 · 2025 $999
Food & beverage: $989Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $211 |
| ABBVIE INC. | 17 | $158 |
| Lilly USA, LLC | 8 | $157 |
| Ardelyx, Inc. | 5 | $91 |
| Phathom Pharmaceuticals, Inc. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| QOL Medical, LLC | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| TerSera Therapeutics LLC | 1 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
Products named: TREMFYA, OMVOH, IBSRELA, VOQUEZNA, ENTYVIO, Sucraid, RINVOQ, LINZESS.
Industry payments across LA — which companies pay providers there.
